126 related articles for article (PubMed ID: 6142245)
21. [Resisting drug propaganda].
Kalsbeek F
Ned Tijdschr Geneeskd; 1973 Jan; 117(4):141-5. PubMed ID: 4683811
[No Abstract] [Full Text] [Related]
22. Complaints about advertising of medicines are encouraged.
Simmonds H
BMJ; 2002 Apr; 324(7341):850-1. PubMed ID: 11934787
[No Abstract] [Full Text] [Related]
23. Student reactions to pharmaceutical promotion practices.
Barnes CJ; Holcenberg JS
Northwest Med; 1971 Apr; 70(4):262-6. PubMed ID: 5550114
[No Abstract] [Full Text] [Related]
24. [Study on the quality of pharmaceutical advertising in a pharmacy in Congo Brazzaville].
Ibiassi JP
Med Trop (Mars); 2006 Dec; 66(6):581-2. PubMed ID: 17286026
[TBL] [Abstract][Full Text] [Related]
25. Use and abuse of advertising in medicine. Advertising and the pattern of prescribing.
Teeling-Smith G
Proc R Soc Med; 1968 Aug; 61(8):748-50. PubMed ID: 5673392
[No Abstract] [Full Text] [Related]
26. Pharmaceutical promotions--a free lunch?
Waud DR
N Engl J Med; 1992 Jul; 327(5):351-3. PubMed ID: 1620175
[No Abstract] [Full Text] [Related]
27. Medical ethics.
Bliznakov EG
Lancet; 2000 Oct; 356(9240):1522. PubMed ID: 11081556
[No Abstract] [Full Text] [Related]
28. Peddling drugs to docs.
Heussner RC
Minn Med; 1994 Jun; 77(6):24-31. PubMed ID: 8041331
[No Abstract] [Full Text] [Related]
29. Misleading advertisements: sanctions and corrections.
Collier J
Lancet; 1984 Nov; 2(8411):1097-8. PubMed ID: 6150167
[No Abstract] [Full Text] [Related]
30. Promotion of medicines.
Massam D
Lancet; 1989 Jun; 1(8650):1330. PubMed ID: 2566856
[No Abstract] [Full Text] [Related]
31. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
Lexchin J
CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415
[TBL] [Abstract][Full Text] [Related]
32. Economic problems in drug distribution.
Rucker TD
Inquiry; 1972 Sep; 9(3):43-50. PubMed ID: 4262974
[No Abstract] [Full Text] [Related]
33. Selling drugs to the public--should the UK follow the example of the US?
Frey J
Br J Gen Pract; 2002 Feb; 52(475):170-1. PubMed ID: 11885831
[No Abstract] [Full Text] [Related]
34. Experimenting with direct-to-consumer advertising.
Lancet; 2000 Aug; 356(9230):607. PubMed ID: 10968426
[No Abstract] [Full Text] [Related]
35. Voluntary control of drug promotion in Sweden.
Perman E
N Engl J Med; 1990 Aug; 323(9):616-7. PubMed ID: 2381456
[No Abstract] [Full Text] [Related]
36. Letter: Misleading drug advertising.
Jouhar AJ
Br Med J; 1975 Apr; 2(5961):38. PubMed ID: 1137785
[No Abstract] [Full Text] [Related]
37. Ethics of drug promotion.
Crompton GK
Br Med J; 1979 Nov; 2(6198):1141. PubMed ID: 42469
[No Abstract] [Full Text] [Related]
38. Promotional literature: how do we critically appraise?
Shetty VV; Karve AV
J Postgrad Med; 2008; 54(3):217-21. PubMed ID: 18626173
[TBL] [Abstract][Full Text] [Related]
39. Television advertising and drug use.
Peterson B; Kuriansky JB; Konheim CS; Anderson RS; Tesar J; Podell RN; Ho A; Cowan NM
Am J Public Health; 1976 Oct; 66(10):975-8. PubMed ID: 970514
[No Abstract] [Full Text] [Related]
40. [Letter: Advertising for Ponderal].
Persson I
Ugeskr Laeger; 1973 Nov; 135(45):2471. PubMed ID: 4773734
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
